STOCK TITAN

Guardian Pharmacy (GRDN) officer lists Class A, B shares and options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. officer Martin David Norman filed an initial ownership report showing direct equity stakes in the company. He holds 101,040 shares of Class A common stock and Class B common stock convertible one-for-one into 39,865 Class A shares on September 27, 2026.

Norman also holds a stock option for 25,000 Class A shares at an exercise price of $34.59 per share, expiring in 2036 and scheduled to vest in full on February 11, 2029. Footnotes additionally describe 7,594 and 4,476 restricted stock units that will each settle one-for-one into Class A shares upon vesting in 2028 and 2029.

Positive

  • None.

Negative

  • None.
Insider Martin David Norman
Role See Remarks
Type Security Shares Price Value
holding Class B Common Stock -- -- --
holding Stock Option (right to buy) -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class B Common Stock — 39,865 shares (Direct); Stock Option (right to buy) — 25,000 shares (Direct); Class A Common Stock — 101,040 shares (Direct)
Footnotes (1)
  1. Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026. This option shall vest and become exercisable in full on February 11, 2029.
Class A common stock 101,040 shares Directly held following Form 3 reporting
Class B convertible underlying shares 39,865 shares Class B automatically converts into Class A on September 27, 2026
Stock option underlying shares 25,000 shares Option to buy Class A common stock
Stock option exercise price $34.59 per share Exercise price for 25,000-share option expiring in 2036
Option vesting date February 11, 2029 Option vests and becomes fully exercisable on this date
RSUs tranche 1 7,594 units RSUs vesting and settling into Class A shares on February 14, 2028
RSUs tranche 2 4,476 units RSUs vesting and settling into Class A shares on March 1, 2029
Class B automatic conversion date September 27, 2026 Class B common stock converts one-for-one into Class A
restricted stock units financial
"Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class B common stock financial
"the Reporting Person's shares of the Issuer's Class B common stock automatically convert..."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A common stock financial
"are settled on a one-for-one basis in shares of ... Class A common stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
automatically convert financial
"Class B common stock automatically convert into shares of the Issuer's Class A common stock..."
Stock Option (right to buy) financial
"Stock Option (right to buy) underlying 25,000 shares of Class A common stock..."
vest and become exercisable financial
"This option shall vest and become exercisable in full on February 11, 2029."
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Martin David Norman

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026
3. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock101,040(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock (2) (2)Class A Common Stock39,865(2)D
Stock Option (right to buy) (3)02/11/2036Class A Common Stock25,000$34.59D
Explanation of Responses:
1. Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock.
2. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
3. This option shall vest and become exercisable in full on February 11, 2029.
Remarks:
Senior Vice President, Technology, Data & Senior Security Officer Exhibit 24.1 - Power of Attorney
/s/ Douglas Towns, Attorney-in-Fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing show for Guardian Pharmacy (GRDN) officer Martin David Norman?

The Form 3 shows Martin David Norman’s initial equity holdings in Guardian Pharmacy Services, Inc., including Class A and Class B common stock, stock options, and restricted stock units, all held directly, with detailed share counts and vesting or conversion terms disclosed.

How many Class A and Class B shares does Martin David Norman hold in GRDN?

Martin David Norman directly holds 101,040 shares of Class A common stock and Class B common stock that is convertible on a one-for-one basis into 39,865 Class A shares, providing a clear picture of his current and eventual common equity exposure.

What stock options does Martin David Norman report in Guardian Pharmacy (GRDN)?

He reports a stock option to acquire 25,000 shares of Guardian Pharmacy’s Class A common stock at an exercise price of $34.59 per share, expiring in 2036, with the option scheduled to vest and become fully exercisable on February 11, 2029.

When will Martin David Norman’s Class B GRDN shares convert into Class A shares?

According to the filing, his Class B common stock automatically converts into Class A common stock on a one-for-one basis on September 27, 2026, establishing a specific future date when those holdings will match the publicly traded Class A shares.

What restricted stock units (RSUs) does Martin David Norman hold in Guardian Pharmacy (GRDN)?

Footnotes state he holds 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, will settle one-for-one into shares of Guardian Pharmacy’s Class A common stock.

Is Martin David Norman’s Form 3 for GRDN reporting a transaction or just holdings?

The Form 3 functions as an initial statement of beneficial ownership, listing Norman’s existing holdings and derivative positions. The records are categorized as holdings rather than new buy or sell transactions, with no open-market trades reported.